OUTPATIENT STEM CELL MOBILIZATION WITH INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE IS A SAFE AND EFFECTIVE PROCEDURE

EHA Library, Alessandra Pompa, 134855

CLINICAL CHARACTERISTICS OF PATIENTS WITH MULTIPLEMYELOMA. PRELIMINARY RESULTS OF A PROSPECTIVEMULTICENTER REGISTRY OF THE COMUNIDAD VALENCIANA(SPAIN).

EHA Library, Javier DE LA RUBIA, 134856

PATIENT REPORTED OUTCOMES (PROS) OF MULTIPLE MYELOMA (MM) PATIENTS FROM THE PANORAMA-1 STUDY WHO HAVE RECEIVED AT LEAST TWO PRIOR REGIMENS INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT.

EHA Library, Paul G Richardson, 134857

RETROSPECTIVE COHORT ANALYSIS EXAMINING THE EFFICACY AND SAFETY OF (V)DTPACE IN NEWLY DIAGNOSED AND RELAPSED/REFRACTORY MYELOMA PATIENTS ? THE UK EXPERIENCE

EHA Library, Priya Sriskandarajah, 134858

THE ROLE OF COMORBIDITY ON EARLY MORTALITY IN MULTIPLE MYELOMA. A SINGLE INSTITUTION POPULATION-BASED STUDY EMPHASIZING THE NEED FOR STANDARDIZATION

EHA Library, Rafael Rios-Tamayo, 134859

CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Masaki Ri, 134860

PROGNOSTIC SIGNIFICANCE OF EXTRAMEDULLARY DISEASE DETECTED BY PET/CT ON OUTCOMES OF AUTOLOGOUS TRANSPLANT IN MULTIPLE MYELOMA PATIENTS

EHA Library, Uday Yanamandra, 134862

ASSOSIATION BETWEEN ENDOTHELIAL AND PLATELET DERIVED MICROPARTICLES AND VENOUS THROMBOSIS IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA (MM) AND NON HODGKIN LYMPHOMA (NHL) - PRELIMINARY REPORT

EHA Library, Lidia Usnarska-Zubkiewicz, 134863

GALECTIN-3 AS A PREDICTOR OF STATIN TREATMENT EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Boris Samura, 134864

CLINICAL SIGNIFICANCE OF OSTEOBLAST PRECURSORS AND OSTEOCLAST PRECURSORS IN EARLIER DIAGNOSIS AND MONITORING OF MYELOMA BONE DISEASE

EHA Library, Rong Fu, 134865

BORTEZOMIB IN COMBINATION WITH HIGH DOSE MELPHALAN AS CONDITIONING REGIMEN IS SAFE AND IMPROVES THE RESPONSE RATES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.

EHA Library, Anna Benedetta Dalla Palma, 134866

OSTEONECROSIS OF THE JAW IN PATIENTS WITH MULTIPLE MYELOMA IN THE ERA OF MORE POTENT BISPHOSPHANATES

EHA Library, Marica Pavkovic, 134867

A PHASE 2 MULTICENTER STUDY OF POMALIDOMIDE IN COMBINATION WITH LOW-DOSE DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: THE MM-011 TRIAL

EHA Library, Shotaro Hagiwara, 134868

IMPACT OF ERYTHROPOIESIS STIMULATING AGENTS ON OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Sebastián Ortiz Zuluaga, 134869

FDG-PET/CT IN MULTIPLE MYELOMA A CORRELATION OF SUV AND ISS SCORE

EHA Library, Brian Østergaard, 134870

INFECTIONS IN MULTIPLE MYELOMA: AN UNDERSTIMATE RISK FACTOR OF COMORBIDITY

EHA Library, Gregorio Barilà, 134871

PREVALENCE OF OCULAR DISORDERS IN MULTIPLE MYELOMA

EHA Library, Martina Pennisi, 134872

BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 134873

SECOND MALIGNANCIES AND MULTIPLE MYELOMA. A SINGLE-INSTITUTION EXPERIENCE IN SPAIN

EHA Library, Seila Cerda, 134874

A PHASE 2 TRIAL OF SMALL-DOSE BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (SVRD) AS CONSOLIDATION/MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tsutomu Sato, 134875

BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS

EHA Library, Celia Suriu, 134876

LEPTOMENINGEAL MYELOMATOSIS ? A RARE COMPLICATION IN MULTIPLE MYELOMA

EHA Library, Martin Bommer, 134877

A PHARMACOKINETICS CLINICAL STUDY OF BORTEZOMIB SUBCUTANEOUS INJECTION VERSUS INTRAVENOUS INJECTION COMBINED WITH CHEMOTHERAPY IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA-INTERIM RESULTS

EHA Library, Zhengzheng Fu, 134878

CHEMOTHERAPY ADHERENCE IS FAVORABLE PROGNOSTIC FACTOR FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA WHO TREATED WITH FRONTLINE BORTEZOMIB CONTAINING REGIMEN

EHA Library, Joon Ho MOON, 134879

PROGNOSTIC SIGNIFICANCE OF EXPRESSION OF MULTIDRUG RESISTANCE GENES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-CONTEINING THERAPHY

EHA Library, Yulia Chernykh, 134880

THE STRATUS TRIAL (MM-010): ANALYSIS OF THE ITALIAN SUBGROUP OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE

EHA Library, Michele Cavo, 134881

RISK OF HYPERTENSION (HTN) AND MALIGNANT HYPERTENSION (MHTN) IN PATIENTS TREATED FOR MULTIPLE MYELOMA (MM)

EHA Library, Ajai Chari, 134882

DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

EHA Library, Marco Capecchi, 134883

TRABECULAR BONE SCORE (TBS) AND DEVELOPMENT OF FRACTURE IN MULTIPLE MYELOMA

EHA Library, Eun Mi Lee, 134884

BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE

EHA Library, Ilina Micheva, 134885

RELAPSED AND REFRACTORY MULTIPLE MYELOMA, EVOLUTION AND COMPLICATIONS SINGLE CENTER EXPERIENCE

EHA Library, Hortensia Ionita, 134886

BENDAMUSTINE, LENALIDOMIDE AND DEXAMETHASONE (BLD) COMBINATION THERAPY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE.

EHA Library, Lucia Ciuffreda, 134887

OUTCOME OF PATIENTS WITH NONSECRETORY AND SECRETORY MULTIPLE MYELOMA AFTER FIRST LINE TREATMENT CONSOLIDATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION. THE SINGLE CENTRE EXPERIENCE

EHA Library, Joanna Romejko-Jarosinska, 134888

PLASMABLASTIC LYMPHOMA (PBL) AND EXTRAMEDULLARY PLASMABLASTIC TRANSFORMATION OF PLASMA CELL MYELOMA (PCM) : DIAGNOSTIC MORHOLOGICAL, IMMUNOHISTOCHEMICAL AND CLINICAL CHARACTERISTICS

EHA Library, Chrissa Vadikolia, 134889

RETROSPECTIVE COMPARISON OF SAFETY AND EFFICACY OF BUCY AND HDM AS REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Song Jin, 134890

CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (CTD) AS INITIAL THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

EHA Library, Jule Vasquez, 134891

PROGNOSTIC FACTORS IN PATIENTS WITH BENCE JONES MULTIPLE MYELOMA

EHA Library, Rafael Rios Tamayo, 134892

COMORBIDITY AS A FACTOR OF PROGNOSIS IN MULTIPLE MYELOMA

EHA Library, Natalia Skvortsova, 134893

PLASMA CELL LEUKEMIA: A 10-YEAR SINGLE CENTER EXPERIENCE

EHA Library, Ana Luisa Pinto, 134894

A SINGLE CENTRE EXPERIENCE OF DPACE-BASED THERAPY WITH LENALIDOMIDE OR THALIDOMIDE +/- BORTEZOMIB PRIOR TO AUTOLOGOUS TRANSPLANT IN MYELOMA

EHA Library, Tracey Parker, 134895

FLOW CYTOMETRY BASED MRD ANALYSIS VERSUS IMMUNOFIXATION ELECTROPHORESIS FOR RESPONSE ASSESSMENT OF MYELOMA PATIENTS ON TREATMENT

EHA Library, Man Updesh Singh Sachdeva, 134896

DIAGNOSIS, PROGNOSIS AND RISK ASSESSMENT OF MULTIPLE MYELOMA: IDENTIFYING GAPS AND ADDRESSING EDUCATION NEEDS FOR HEMATOLOGISTS AND ONCOLOGISTS

EHA Library, Emily Van Laar, 134897

IDENTIFICATION OF MULTIPLE MYELOMA IN PATIENTS ATTENDING EMERGENCY SERVICES WITH SEVERE BONE PAIN

EHA Library, Rafael Rios Tamayo, 134898

LIGHT-CHAIN ESCAPE IN MULTIPLE MYELOMA : A NEW PATTERN OF DISEASE RELAPSE CHANGING BIOLOGY. A SINGLE-CENTER EXPERIENCE OF THREE CASES

EHA Library, Lorenza Torti, 134899

DOMESTIC SUBCUTANEOUS SELF-INJECTION OF BORTEZOMIB IN MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 134900

AL AMYLOIDOSIS: REAL WORLD EVIDENCE FROM ARGENTINA

EHA Library, ELSA NUCIFORA, 134901

RETROSPECTIVE STUDY OF THE EFFICACY, ECONOMY AND SAFETY OF TREATMENT WITH SUBCUTANEOUS INJECTION OF BORTEZOMIB IN DE NOVO PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Zhengzheng Fu, 134902

THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH BORTEZOMIB TREATMENT IN MULTIPLE MYELOMA

EHA Library, Alexandra Pedraza, 134903

A SINGLE CENTRE REAL LIFE EXPERIENCE ON MULTIPLE MYELOMA (MM) PATIENTS: SUBCUTANEOUS ( SUBQ) VERSUS INTRAVENOUS (IV) BORTEZOMIB (BOR).

EHA Library, Maria Stefania Infante, 134904

REAL WORLD EXPERIENCE OF BORTEZOMIB RE-TREATMENT FOR PATIENTS WITH MULTIPLE MYELOMA AT FIRST RELAPSE

EHA Library, Yasmin Reyal, 134905

FIRST EXPERIENCES WITH GENERIC BORTEZOMIB ADMINISTRATION ?ONE CENTRE EXPERIENCE

EHA Library, Alexandra JUNGOVA, 134906

DEVELOPMENT OF RAS-INDUCED ZEBRAFISH LEUKEMIA MODELS

EHA Library, Claudia Lengerke, 134907

MOLECULAR AND CYTOGENETIC PROFILE OF PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Liubov Poluskina, 134908

ASSESSMENT OF THE INTERLABORATORY VARIABILITY AND ROBUSTNESS OF JAK2V617F MUTATION ASSAYS: A STANDARDIZATION STUDY INVOLVING A CONSORTIUM OF 19 ITALIAN LABORATORIES

EHA Library, Margherita Perricone, 134909

PHARMACOLOGICAL ACTIVITY PROFILING OF PACRITINIB IN THE BIOMAP

EHA Library, Rebecca Watson, 134910

A NOVEL REAL-TIME PCR ASSAY SET FOR DETECTION OF DIVERSE CALR MUTATIONS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Roland Jager, 134911

THE S100 PROTEINS AS MEDIATORS OF INFLAMMATION ARE INCREASED IN MYELOPROLIFERATIVE NEOPLASM AND DOWNREGULATED BY JAK2 INHIBITION

EHA Library, Olivera Mitrovic, 134912

HIGH SENSITIVITY MLPA ASSAY FOR THE DETECTION OF THE RECURRENT CALR, JAK2, KIT AND MPL MUTATIONS WITH ? 1% ALLELE BURDEN IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Maryvonne Steenkamer, 134913

FUNCTIONAL STUDY OF TWO NEW POINT MUTATIONS OF EPOR GENE IN PRIMARY FAMILIAL CONGENITAL POLYCYTHEMIA

EHA Library, Maria Luigia Randi, 134914

CLINICAL-BIOLOGICAL PROFILE AND RESPONSE TO IMATINIB IN MYELOID AND LYMPHOID NEOPLASM ASSSOCIATED WITH EOSINOPHILIA AND IDIOPATHIC HYPEREOSINOPHILIC SYMDROME

EHA Library, Francisca Hernandez Mohedo, 134917

BASELINE CHARACTERISTICS AND RISK FACTORS FOR LEUKEMIA-FREE AND OVERALL SURVIVAL IN BULGARIAN PATIENTS WITH PRIMARY MYELOFIBROSIS ? A NATIONAL COHORT STUDY

EHA Library, Margarita Guenova, 134918

DISEASE CHARACTERIZATION AND TREATMENT PATTERNS OF PATIENTS WITH MYELOFIBROSIS: ANALYSIS OF US CLAIMS DATABASES

EHA Library, Maneesha Mehra, 134919

RISK FACTORS AND OUTCOMES OF ASIAN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS) IN LEUKAEMIC TRANSFORMATION

EHA Library, Grace Kam, 134920

SAFETY AND EFFICACY OF RUXOLITINIB IN CLINICAL PRACTICE FOR PRIMARY AND SECONDARY MYELOFIBROSIS

EHA Library, Massimo Breccia, 134921

RESULTS IN ELDERLY CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS TREATED WITH 5-AZACYTIDINE.

EHA Library, Dunia De Miguel Llorente, 134922

ONLINE STREAMING YOGA IS A FEASIBLE NON-PHARMACOLOGIC MANAGEMENT STRATEGY IN MYELOPROLIFERATIVE NEOPLASM PATIENTS

EHA Library, Jennifer Huberty, 134923

ASCITES - A MANIFESTATION OF AGGRESSIVE SYSTEMIC MASTOCYTOSIS - CAN SUCCESSFULLY BE TREATED WITH MIDOSTAURIN (PKC412)

EHA Library, Ingunn Dybedal, 134924

QUALITY OF LIFE AND SYMPTOM BURDEN IN MYELOFIBROSIS PATIENTS:A REAL WORLD STUDY

EHA Library, Tatyana Ionova, 134925

?FIBRINOGEN G-455-A GENE POLYMORPHISM: IS IT A FACTOR FOR ASPIRIN PLATELET INSENSIVITY IN PATIENTS WITH POLYCYTHEMIA VERA?

EHA Library, Rossella Cacciola, 134926

ESSENTIAL THROMBOCYTHEMIA WITH JAK2 V617F OR CALR MUTATION: TWO DIFFERENT PHENOTYPES

EHA Library, Alba Sara , 134927

CLINICAL IMPORTANCE OF ?2 GLYCOPROTEIN I ANTIBODIES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Abdulkadir Basturk, 134928

NEW PROPOSED WHO CRITERIA FOR THE PV DIAGNOSIS: A CLINICAL OVERLOAD PROBLEM?

EHA Library, Melania Moreno Vega, 134929

PREVALENCE OF THE JAK2 V617F MUTATION IN SOME COHORTS OF THE CENTRAL SIBERIA (KRASNOYARSK REGION) POPULATION

EHA Library, Igor Olkhovskiy, 134930

CLINICAL FEATURES OF LATENT / MASKED POLYCYTHEMIA VERA (SINGLE CENTER EXPERIENCE).

EHA Library, Irina Soubortseva, 134931

?LINICAL FEATURES AND MOLECULAR MARKERS IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Anastasiia Zherniakova, 134932

IMPLEMENTATION OF THE JAK2 V617F MUTATION ANALYSIS IN THE DIAGNOSIS OF SUSPECTED MYELOPROLIFERATIVE NEOPLASMS IN CAPE TOWN

EHA Library, Estelle Verburgh, 134933

RUXOLITINIB IN MYELOFIBROSIS: A TWO-CENTRE EXPERIENCE

EHA Library, James Russell, 134934

CLINICAL SIGNIFICANCE OF ANISOCYTOSIS IN NEWLY-DIAGNOSED PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Marko Lucijanic, 134935

RISK FACTORS FOR THROMBOTIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Evica Simonovic, 134936

JAK2, MPL, AND CALR MUTATIONS IN CHINESE HAN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Jingyan XU, 134937

WHAT IS THE SECRET OF THE JAK2 MUTATION ALLELE LOAD STABILITY IN SOME PATIENTS WITH MPN?

EHA Library, Tatiana Subbotina, 134938

PLATELET COUNT AS A RISK FACTOR FOR HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Evica Simonovic, 134939

PROLIFERATING KI67 EXPRESSING B-CELLS ASSOCIATE WITH CD4+PD1+ T-CELLS IN MARGINAL ZONE LYMPHOMA.

EHA Library, Katherine Wickenden, 134940

CLINICAL IMPLICATIONS OF MYD88 L265P MUTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Anna Sidorova, 134941

QUINACRINE SYNERGIZES WITH DOXORUBICIN IN INHIBITING THE SURVIVAL OF DLBCL CELL BY SUPPRESSING NF-KB AND ALTERING CELL-CYCLE PROGRESSION

EHA Library, Yang Shujun, 134942

VALIDATION OF LST EUROFLOW

EHA Library, Alejandro Berkovits, 134943

IMPACT OF THE NAGASAKI ATOMIC BOMB ON THE INCIDENCE RATE AND OUTCOME OF FOLLICULAR LYMPHOMA

EHA Library, Tatsuro Jo, 134944

CD39 EXPRESSION ON CD4 T INFILTRATING LYMHOCYTES IN THE TUMOR MICROENVIRONMENT OF LYMPHOMAS

EHA Library, Rosa Di Gaetano, 134945

SERUM PROTEOMIC PROFILES OF HODGKIN?S LYMPHOMA PATIENTS SHOW DIFFERENTIAL EXPRESSION ACCORDING TO EPSTEIN-BARR VIRUS STATUS

EHA Library, Juliane Musacchio, 134946

EVALUATION OF NEUTROPHIL-LYMPHOCYTE RATIO IN PATIENTS WITH MYCOSIS FUNGOIDES

EHA Library, Rafet Eren, 134947

TO DOSE OR NOT TO DOSE: ARE IL-10 AND IL-10:IL-6 RATIO ACCURATE BIOMARKERS TO DETECT LEPTOMENINGEAL INVOLVEMENT IN SMALL B-CELL LYMPHOPROLIFERATIONS?

EHA Library, Myrto Costopoulos, 134948

PROGRESS IN THE DIAGNOSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Agathe Debliquis, 134949

CSF IGH REARRANGEMENT IN HIGH-RISK DLBCL PATIENTS TREATED WITH INTRATHECAL PROPHYLAXIS

EHA Library, Maria Chiara Tisi, 134950

HODGKIN'S LYMPHOMA AND AUTOIMMUNE DISEASES

EHA Library, Benhabiles Rym, 134951

EFFECTS OF MICRORNA-21 ON APOPTOSIS BY REGULATING THE EXPRESSION OF PTEN IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Rong Fu, 134952

PROSPECTIVE COMPARATIVE STUDY BETWEEN CYTOLOGY COUPLED TO THE FLOW CYTOMETRY BY FINE NEEDLE ASPIRATION AND HISTOLOGY IN THE DIAGNOSIS AND CLASSIFICATION OF LARGE B CELL LYMPHOMA

EHA Library, ABBADI Mohamed Rafik, 134953

THE DURATION OF FIRST COMPLETE REMISSION OF DIFFUSE LARGE B CELL LYMPHOMA COMPARED TO NONGCB, MUM1/IRF4, AND EXPRESSION OF BCLXL AND KI67 IN IMMUNOCHEMOTHERAPY ERA

EHA Library, Alma Sofo Hafizovic, 134954

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: EXPERIENCE OF AN HOSPITAL IN NORTHEN SPAIN IN THE LAST 22 YEARS

EHA Library, Violeta Martinez-Robles, 134955

SPLEEN ENLARGEMENT AS ONLY MANIFESTATION OF NIEMANN PICK DISEASE TYPE C

EHA Library, Laura López De, 134956

THROMBOPOIETIN MIMETICS AS ?A BRIDGE TO RECOVERY?. SINGLE CENTER EXPERIENCE IN FOUR PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA.

EHA Library, Ugo Consoli, 134957